Moderate coding expectations
Network Engineer interviews focus more on networking fundamentals and troubleshooting than complex algorithms. Expect basic scripting and automation questions.
1 roles from funded startups and hidden sources. Posted
minutes ago. Updated every 60 seconds
Focus areas that matter most for network engineering positions. Explore key insights and preparation tips to help you excel in your interview process.
Network Engineer interviews focus more on networking fundamentals and troubleshooting than complex algorithms. Expect basic scripting and automation questions.
Design scalable network infrastructures, implement security protocols, and optimize traffic flow for enterprise environments.
Network Topology
Campus & WAN design
Security Architecture
Firewall & VPN implementation
Traffic Engineering
Load balancing & QoS
Different company types emphasize various networking skills and experience levels.
Cisco, Juniper
Protocol expertise and vendor certifications
AWS, Google Cloud
Cloud networking and automation skills
Compare cost-of-living buying power and how crowded the market is versus other major tech cities—so you can focus your search where the odds fit your goals.
Baltimore offers approximately 40% lower housing costs and 35% lower overall cost of living compared to San Francisco, allowing network engineers to maximize their earning potential while enjoying waterfront living, historic neighborhoods, and proximity to Washington DC's tech corridor.
Baltimore's network engineering market shows healthy demand with lower saturation than major tech hubs. Strong government contractor presence and healthcare systems create steady opportunities.

New roles go live every minute and the earliest applicants win. Get the freshest, verified listings delivered straight to your inbox before most job seekers ever see them.
👉 Get free daily job postsPearl Diagnostics is a Baltimore-based biotech spun out of Johns Hopkins University in 2014 that builds non-invasive urine-based diagnostic tests for lung infections. Its flagship MycoMEIA Aspergillus urine assay, which received FDA 510(k) clearance in August 2025 and CE approval for the EU, replaces invasive bronchoalveolar lavage procedures used to detect aspergillosis in transplant recipients, cancer patients, and immunocompromised individuals. The company is extending the same antigen-detection platform to other fungal and bacterial pathogens, including a Pseudomonas assay for cystic fibrosis patients.
Raised
$11.2M
Series A · 2026
Key contacts
-
Leadership & hiring contacts indexed
HQ market
Baltimore, Maryland
United States